Matthew J Schipper
Overview
Explore the profile of Matthew J Schipper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
2452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allen S, Schonewolf C, Schipper M, Yin H, Paximadis P, Kestin L, et al.
Int J Radiat Oncol Biol Phys
. 2025 Mar;
PMID: 40074046
Purpose/objective(s): Use of intensity-modulated radiation therapy (IMRT) versus three-dimensional conformal external beam radiation therapy (3D-CRT) for definitive chemoradiation therapy (CRT) in locally advanced non-small cell lung cancer (LA-NSCLC) has been...
2.
Chung D, Caverly T, Schipper M, Hofer T, Gulati R, Rose B, et al.
JAMA Netw Open
. 2025 Feb;
8(2):e2459766.
PMID: 39951264
Importance: Continuing prostate-specific antigen (PSA) screening after age 70 years might benefit men at high risk of prostate cancer-specific mortality (PCSM) or metastatic prostate cancer (mPCa), but the relative value...
3.
Dykstra M, Regan S, Yin H, McLaughlin P, Boike T, Bhatt A, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jun;
120(4):999-1007.
PMID: 38844140
Purpose: For men with intermediate-risk prostate cancer treated with definitive therapy, the addition of androgen deprivation therapy (ADT) reduces the risk of distant metastasis and cancer-related mortality. However, the absolute...
4.
Roberts E, Luo L, Mondul A, Banerjee M, Veenstra C, Mariotto A, et al.
Cancer Causes Control
. 2024 May;
35(10):1393-1405.
PMID: 38811511
Purpose: Surveillance, Epidemiology, and End Results (SEER) cancer registries provides information about survival duration and cause of death for cancer patients. Baseline demographic and tumor characteristics such as age, sex,...
5.
Gharzai L, Morris E, Suresh K, Nguyen-Tan P, Rosenthal D, Gillison M, et al.
Lancet Oncol
. 2024 Feb;
25(3):366-375.
PMID: 38423050
Background: The increased incidence of human papillomavirus (HPV)-related cancers has motivated efforts to optimise treatment for these patients with excellent prognosis. Validation of surrogates for overall survival could expedite the...
6.
Rankin J, Bedrava J, Covington E, Johnson J, Pollard-Larkin J, Schipper M, et al.
Int J Radiat Oncol Biol Phys
. 2024 Feb;
119(5):1336-1343.
PMID: 38387813
Purpose: Women remain underrepresented in medical physics in the United States, and determinants of persisting disparities remain unclear. Here, we performed a detailed investigation of American Association of Physicists in...
7.
Gharzai L, Jiang R, Jaworski E, Morales Rivera K, Dess R, Jackson W, et al.
NEJM Evid
. 2024 Feb;
2(4):EVIDoa2200195.
PMID: 38320030
BACKGROUND: The Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP) working group identified metastasis-free survival as a valid surrogate end point for overall survival (OS) for patients with localized...
8.
Ramanathan S, Hochstedler K, Laucis A, Movsas B, Stevens C, Kestin L, et al.
Clin Lung Cancer
. 2024 Jan;
25(4):e201-e209.
PMID: 38290875
Introduction: Treatment for inoperable stage II to III non-small cell lung cancer (NSCLC) involves chemo-radiotherapy (CRT). However, some patients transition to hospice or die early during their treatment course. We...
9.
Das R, Abbott M, Hadley S, Sahai V, Bednar F, Evans J, et al.
Adv Radiat Oncol
. 2023 Dec;
8(6):101266.
PMID: 38047228
Purpose: Patients with pancreatic cancer undergoing chemoradiation therapy may experience acute and chronic side effects. We conducted an exploratory analysis of patients with locally advanced pancreatic cancer (LAPC) undergoing definitive...
10.
Wang C, Peterson A, Wong K, Roseland M, Schipper M, Dewaraja Y
J Nucl Med
. 2023 Jul;
64(9):1463-1470.
PMID: 37500260
Estimation of the time-integrated activity (TIA) for dosimetry from imaging at a single time point (STP) facilitates the clinical translation of dosimetry-guided radiopharmaceutical therapy. However, the accuracy of the STP...